CD274 and head and neck neoplasm: Greater antitumor activity was recorded in patients with squamous cell carcinoma tumors of the head and neck that expressed higher levels of PD-L1 and interferon-γ-related genes. Thus, pembrolizumab might represent a new treatment approach for patients with squamous cell carcinoma of the head and neck